SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Biocon Secures Yesintek Market Entry in Additional Global Markets

Biocon said it secured market entry for Yesintek, a proposed biosimilar to Stelara, in additional global markets. It said it inked a licence agreement with Janssen Sciences Ireland.

BIOCON

Related stories